Skip to main navigation
Skip to main content
Skip to page footer
Back
StratifAI
StratifAI develops AI-driven digital biomarkers for precision oncology to significantly improve treatment decisions in cancer care. The Polaris data analysis platform uses machine learning to accurately predict patients' risk of recurrence from routinely available histological data and genetic information. The target audience includes hospitals, oncologists, and healthcare providers looking to provide cancer patients with the best individual therapy in a timely and targeted manner.
